The global amniotic membrane market size reached US$ 1.5 billion in 2023. Looking ahead, IMARC Group projects the market to grow to US$ 3.2 billion by 2032, with a compound annual growth rate (CAGR) of 8% from 2024 to 2032. Major factors driving this growth include the rising preference for minimally invasive treatments, the increasing prevalence of chronic conditions such as diabetes and rheumatoid arthritis, and the expansion of specialized clinics and hospitals.
